https://comparerx.org/news/semaglutide-trial-employment-housing-recidivism-telehealth CompareRx.org en 2026-10-14T12:15:27.881Z Semaglutide study tracks housing and criminal justice outcomes — what 'life impact' data changes for US buyers https://comparerx.org/news/glp1-diabetic-macular-edema-safety-telehealth-buyers CompareRx.org en 2026-10-14T00:15:26.904Z GLP-1s do not increase diabetic eye injection frequency — what the safety data changes for US buyers https://comparerx.org/news/novo-discontinues-saxenda-shifts-buyers-weekly-glp1 CompareRx.org en 2026-10-13T20:15:24.347Z Novo Nordisk to discontinue Saxenda by 2027 — accelerating the telehealth shift to weekly GLP-1s